GPC Biotech gpc-biotech.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

GPC Biotech AG is a publicly traded biopharmaceutical company focused on anticancer drugs. GPC Biotech's lead product candidate is satraplatin, an oral platinum compound. The Company has various anti-cancer programs in research and development that leverage its expertise in kinase inhibitors. GPC Biotech AG is headquartered in Martinsried/Munich (Germany) and has a wholly owned U.S. subsidiary in Princeton, New Jersey.

GPC Biotech AG is a publicly traded biopharmaceutical company focused on anticancer drugs. GPC Biotech's lead product candidate is satraplatin, an oral platinum compound. The Company has various anti-cancer programs in research and development t...Show all

Company (Acquired)

Phone: 609-524-1000

Fax:

101 College Road East
Princeton, 08540
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
GPC Biotech $0M Mar 6, 2000
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related GPC Biotech Jobs

jobs by Indeed job
						search

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Immunosuppressant compounds, methods and uses related thereto Mar 24, 2003 Dec 08, 2009 Patent
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto Apr 07, 2004 Oct 20, 2009 Patent
E6ap-binding proteins Jun 07, 1995 Jul 28, 2009 Patent
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells Nov 15, 2001 Apr 21, 2009 Patent